As the title of this blog indicates, my latest (Nov 1, 2023) PD Adequacy Test indicates I am not getting enough PD treatment. In October 2023 my reading was 1.7 and now it’s 1.56 with a downward trend since April 2023 as you may readily ascertain from the graph above.

I have a dialysis team meeting coming up on Friday, 11/9/2023 during which I’m certain changes in my dialysis prescription will result. Such changes could range from increasing the amount of dextrose fluid per exchange that is utilized, to its strength, to the length of dwells, to change of medication such as the diuretic Hydrochlorothiazide I currently am prescribed. As I currently only stock 5L and 3L bags of dextrose, this could have an impact on my supply inventory and consequent supply ordering from Fresenius.

So my wKt/V has changed. Turns out as previously reported, so has a colleague’s in Greensboro, NC. To ascertain what may be causal in this change, I turned to my AI assistant with the Prompt in blue below with the following results for all of our edification:

Title: Understanding Peritoneal Dialysis Adequacy Test Decreases: Causes and Nephrologist’s Response

Introduction:

Peritoneal dialysis (PD) is a vital treatment option for individuals with end-stage renal disease (ESRD). Regular assessment of peritoneal dialysis adequacy is crucial in ensuring the effectiveness of the treatment. However, there are instances when the peritoneal dialysis adequacy test may indicate a decrease in efficiency. In this blog post, we will explore the potential causes behind this decrease and the steps typically taken by nephrologists in response. It is worth noting that your use of the diuretic Hydrochlorothiazide may have some implications in this context.

Causes of Peritoneal Dialysis Adequacy Test Decrease:

Peritoneal Membrane Changes: Over time, the peritoneal membrane, which serves as the dialysis filter, may undergo structural changes. This can lead to a decrease in the efficiency of solute and fluid removal during PD.

Infection or Inflammation: Infections or inflammation of the peritoneum, known as peritonitis, can impair the function of the peritoneal membrane. It can lead to decreased dialysate flow, reduced ultrafiltration, and compromised clearance of waste products.

Catheter Dysfunction: The peritoneal dialysis catheter is responsible for delivering and draining the dialysate. Catheter-related issues such as blockages, malpositioning, or infections can impede the dialysis process and result in inadequate clearance.

Medications: Certain medications, including diuretics like Hydrochlorothiazide, can affect the fluid balance in the body. While diuretics are commonly used to manage fluid overload, excessive diuresis can impact the fluid status required for effective PD.

Nephrologist’s Response:

Comprehensive Assessment: When faced with a decrease in peritoneal dialysis adequacy, nephrologists begin by conducting a thorough assessment of the patient. This includes reviewing medical history, and current medications, and conducting physical exams to identify potential causes.

Evaluation of Peritoneal Membrane Function: Nephrologists may order tests such as a peritoneal equilibration test (PET) to evaluate the transport characteristics of the peritoneal membrane. This helps determine if structural changes in the membrane contribute to the decrease in adequacy.

Infection Management: If peritonitis is suspected, prompt initiation of appropriate antibiotic therapy is crucial. Cultures may be obtained to identify the causative organism and guide treatment. Resolving the infection can improve peritoneal dialysis adequacy.

Catheter Assessment and Intervention: Nephrologists closely evaluate the peritoneal dialysis catheter for any signs of dysfunction or infection. If necessary, interventions such as catheter repositioning, flushing, or replacement may be recommended to restore adequate dialysate flow.

Medication Adjustment: In the case of medications that may impact fluid balance, nephrologists may consider adjusting the dosage or switching to alternative medications. This helps maintain the delicate fluid balance required for effective peritoneal dialysis.

Conclusion:

Peritoneal dialysis adequacy is a crucial aspect of effective renal replacement therapy. The causes of a decrease in adequacy can range from peritoneal membrane changes to medication-related factors. Nephrologists play a vital role in investigating and addressing these issues promptly. By conducting comprehensive assessments and implementing appropriate interventions, they strive to optimize peritoneal dialysis outcomes and improve the overall well-being of their patients. If you have concerns about the adequacy of your peritoneal dialysis, it is important to consult with your nephrologist, who can provide personalized guidance based on your specific situation.